A recent study showed that deletion of C/EBPβ in human breast cancer cells (BT-20) results in the de-repression of genes involved in immune visibility, where MHC I and MHC II gene sets were significantly upregulated as compared to wildtype (56). This evidence concerns the gene CEBPB and breast cancer.